General Information of Drug-Metabolizing Enzyme (DME ID: DME1091)
DME Name Kanamycin/gentamycin-resistance enzyme (aacA), Campylobacter coli DME Info
UniProt ID
J3S7E2_CAMCO
EC Number    EC: 2.7.1.190     (Click to Show/Hide the Complete EC Tree)
Transferase
Kinase
Phosphotransferase
EC: 2.7.1.190
Lineage    Species: Campylobacter coli     (Click to Show/Hide the Complete Species Lineage)
Kingdom: Bacteria
Phylum: Proteobacteria
Class: Epsilonproteobacteria
Order: Campylobacterales
Family: Campylobacteraceae
Genus: Campylobacter
Species: Campylobacter coli
Interactome
Disease Specific Interactions between Host Protein and DME (HOSPPI)
      Drug co-metabolism
               Cometabolized drug: Tobramycin Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                            RNA cytidine acetyltransferase (hALP) Click to Show/Hide the Cometabolization Info
DME ID DME0007 DME Info
Uniprot ID
NAT10_HUMAN
Interaction Name hALP-aacA interaction [1], [2]
Description The interaction, between human RNA cytidine acetyltransferase and Kanamycin/gentamycin-resistance enzyme from Campylobacter coli which collectively metabolize the drug Tobramycin, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism.
References
1 Cloning and expression of novel aminoglycoside phosphotransferase genes from Campylobacter and their role in the resistance to six aminoglycosides. Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01682-17.
2 Genetic analysis of bacterial acetyltransferases: identification of amino acids determining the specificities of the aminoglycoside 6'-N-acetyltransferase Ib and IIa proteins. J Bacteriol. 1992 May;174(10):3196-203.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.